These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25868710)

  • 1. Ketotifen use in a patient with fire ant hypersensitivity and mast cell activation syndrome.
    Asawa A; Simpson KH; Bonds RS
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):443-6. PubMed ID: 25868710
    [No Abstract]   [Full Text] [Related]  

  • 2. Imported fire ant hypersensitivity and mastocytosis: A case series of successful venom immunotherapy.
    Nath P; Adams K; Schapira R; Edwards K
    Ann Allergy Asthma Immunol; 2019 May; 122(5):541-542. PubMed ID: 30831255
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal anaphylaxis to indoor native fire ant stings in an infant.
    More DR; Kohlmeier RE; Hoffman DR
    Am J Forensic Med Pathol; 2008 Mar; 29(1):62-3. PubMed ID: 19749619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hymenoptera stings.
    Fitzgerald KT; Flood AA
    Clin Tech Small Anim Pract; 2006 Nov; 21(4):194-204. PubMed ID: 17265905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ketotifen (Zaditen and K-Asthmal): a drug with sales disproportionate to its demonstrated effectiveness].
    Pérez-Padilla JR
    Gac Med Mex; 1999; 135(2):165-70. PubMed ID: 10327750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of mastocytic anaphylactic episodes with reduction of skin mast cells after anti-IgE therapy.
    Paraskevopoulos G; Sifnaios E; Christodoulopoulos K; Mantopoulou F; Papakonstantis M; Sabaziotis D
    Eur Ann Allergy Clin Immunol; 2013 Apr; 45(2):52-5. PubMed ID: 23821833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis.
    Jung HW; Jung JK; Park YK
    Int Immunopharmacol; 2013 Jun; 16(2):254-60. PubMed ID: 23643816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio-oedema.
    Pressler A; Grosber M; Halle M; Ring J; Brockow K
    Clin Exp Dermatol; 2013 Mar; 38(2):151-3. PubMed ID: 22731986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketotifen versus inhaled budesonide for controlling childhood asthma.
    Tantichaiyakul P; Preutthipan A
    J Med Assoc Thai; 2010 May; 93(5):541-9. PubMed ID: 20524439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    Castells M; Butterfield J
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1097-1106. PubMed ID: 30961835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ketotifen in bronchial asthma.
    Benos S; Karasiotos G; Kalatzi N
    Allergol Immunopathol (Madr); 1979; 7(3):223-6. PubMed ID: 38658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models.
    Cheng C; Ng DS; Chan TK; Guan SP; Ho WE; Koh AH; Bian JS; Lau HY; Wong WS
    Allergy; 2013 Feb; 68(2):195-203. PubMed ID: 23253152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ketotifen in the prevention of bronchial asthma. International therapeutic evaluation].
    Craps L
    Allergol Immunopathol (Madr); 1981; Suppl 9():177-90. PubMed ID: 6131598
    [No Abstract]   [Full Text] [Related]  

  • 15. Ketotifen and chronic urticaria.
    Taşkapan O; Harmanyeri Y
    Arch Dermatol; 1998 Feb; 134(2):240-1. PubMed ID: 9487221
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic potential of ketotifen in irritable bowel syndrome (IBS) may involve changes in mast cells at sites beyond the rectum.
    O'Sullivan M
    Gut; 2011 Mar; 60(3):423; author rpely 423. PubMed ID: 20921205
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of recurrent wheezing in young children by loratadine compared with ketotifen.
    Ngamphaiboon J; Wirawarn T; Thongkaew T
    J Med Assoc Thai; 2009 Mar; 92(3):351-5. PubMed ID: 19301727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylaxis caused by imported red fire ant stings in Málaga, Spain.
    Fernández-Meléndez S; Miranda A; García-González JJ; Barber D; Lombardero M
    J Investig Allergol Clin Immunol; 2007; 17(1):48-9. PubMed ID: 17323863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [IgE mediated food allergy: pathomechanism, clinical picture and perspectives of new therapy].
    Romański B
    Pol Merkur Lekarski; 1998 Dec; 5(30):379-83. PubMed ID: 10101530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.